HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading

Immunity

Volumn 8, Issue 5, 1998, Pages 531-542

  Peh, Chen Au ^a   Burrows, Scott R ^b   Barnden, Megan ^e   Khanna, Rajiv ^b   Cresswell, Peter ^d   Moss, Denis J ^b   McCluskey, James ^a,c,e  

^a FLINDERS UNIVERSITY   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CELL MEMBRANE PROTEIN; HLA B27 ANTIGEN; TAPASIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGENIC VARIATION; ARTICLE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032076171     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80558-0     Document Type: Article

References (73)

1. Ahn, K., Gruhler, A., Galocha, B., Jones, T.R., Wietz, E.J.H.J., Ploegh, H., Peterson, P.A., Yang, Y., and Fruh, K. (1997). The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6, 613-621.
2. Benjamin, R., and Parham, P. (1990). Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol. Today 11, 137-142.
3. Benjamin, R., Madrigal, J., and Parham, P. (1991). Peptide binding to empty HLA-B27 molecules of viable human cells. Nature 351, 74-77.
4. Breban, M., Fernandez-Sueiro, J.L., Richardson, J.A., Hadavand, R.R., Maika, S.D., Hammer, R.E., and Taurog, J.D. (1996).T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J. Immunol. 156, 794-803.
5. Brooks, A.G., Campbell, P.L., Reynolds, P., Gautam, A.M., and McCluskey, J. (1994). Antigen presentation and assembly by mouse I-AK class II molecules in human APC containing deleted or mutated HLA DM genes. J. Immunol. 153, 5382-5392.
6. Burrows, S.R., Rodda, S.J., Suhbier, A., Geysen, H.M., and Moss, D.J. (1992). The specificity of recognition of acytotoxic Tlymphocyte epitope. Eur. J. Immunol. 22, 191-195.
7. Burrows, S.R., Gardner, J., Khanna, R., Steward, T., Moss, D.J., Rodda, S., and Suhrbier, A. (1994). Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3. J. Gen. Virol. 75, 2489-2493.
8. Carreno, B.M., Solheim, J.C., Harris, M., Stroynowski, I., Connolly, J.M., and Hansen, T.H. (1995). TAP associates with a unique class I conformation, whereas calnexin associates with multiple class I forms in mouse and man. J. Immunol. 155, 4726-4733.
9. Cerundolo, V., Kelly, A., Elliott, T., Trowsdale, J., and Townsend, A. (1995). Genes encoded in the major histocompatibility complex affecting the generation of peptidesfor TAP transport. Eur. J. Immunol. 25, 554-562.
10. Denzin, L.K., Hammond, C., and Cresswell, P. (1996). HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184, 2153-2165.
11. DiBrino, M., Parker, K.C., Margulies, D.H., Shiloach, J., Turner, R.V., Biddison, W.E., and Coligan, J.E. (1995). Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the caucasian population. Biochemistry 34, 10130-10138.
12. Elliott, T. (1997). How does TAP associate with MHC class I molecules? Immunol. Today 18, 375-379.
13. Ellis, S.A., Taylor, C., and McMichael, A. (1982). Recognition of HLA-B27 and related antigen by a monoclonal antibody. Hum. Immunol. 5, 49-59.
14. Fruh, K., Ahn, K., Djaballah, H., Sempe, P., van Endert, P.M., Tampe, R., Peterson, P.A., and Yang, Y. (1995). A viral inhibitor of peptide transporters for antigen presentation. Nature 375, 415-418.
15. Gillis, S., and Watson, J. (1980). Biochemical and biological characterisation of lymphocyte regulatory molecules. V: identification of an interleukin 2-producing human leukemia T cell line. J. Exp. Med. 152, 1709-1719.
16. Grandea, A.G. III, Androlewicz, M.J., Athwal, R.S., Geraghty, D.E., and Spies, T. (1995). Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science 270, 105-108.
17. Grandea, A.G. III, Lehner, P.J., Cresswell, P., and Spies, T. (1997). Regulation of MHC class I heterodimer stability and interaction with TAP by tapasin. Immunogenetics 46, 477-483.
18. Greenwood, R., Shimizu, Y., Sekhon, G.S., and DeMars, R. (1994). Novel allele-specific, post-translational reduction in HLA class I surface expression in a mutant human B cell line. J. Immunol. 153, 5525-5536.
19. Grumet, F.C., Fendly, B.M., and Engleman, E.G. (1981). Monoclonal anti-HLA-B27 antibody (B27M1): production and lack of detectable typing difference between patients with ankylosing spondylitis, Reiter's syndrome, and normal controls. Lancet 2, 174-176.
20. Hammer, R.E., Maika, S.D., Richardson, J.A., Tang, J.-P., and Taurog, J.L. (1990). Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2-m: an animal model of human HLA-B27 associated disorders. Cell 63, 1099-1112.
21. Henderson, R.A., Michel, H., Sakaguchi, K., Shabanowitz, J., Appella, E., Hunt, D.F., and Engelhard, V.H. (1992). HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 255, 1263-1266.
22. Hengel, H., Koopmann, J.-O., Flohr, T., Muranyi, W., Goulmy, E., Hammerling, G.J., Koszinowski, U.H., and Momburg, F. (1997). A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6, 623-632.
23. Hermann, E., Yu, D.T.Y., Meyer zum Büschenfelde, K.-H., and Fleischer, B. (1993). HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 342, 646-650.
24. Hill, A.V.S., Elvin, J., Willis, A.C., Aidoo, M., Allsopp, C.E.M., Gotch, F.M., Gao, X.M., Takiguchi, M., Greenwood, B.M., and Townsend, A.R.M. (1992). Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360, 434-439.
25. Hill, A., Jugovic, P., York, I., Ruus, G., Bennink, J., Yewdell, J., Ploegh, H., and Johnson, D. (1995). Herpes simplex virus turns off the TAP to evade host immunity. Nature 375, 411-415.
26. Howard, J.C. (1995). Supply and transport of peptides presented by class I MHC molecules. Curr. Opin. Immunol. 7, 69-76.
27. Hughes, E.A., Hammond, C., and Cresswell, P. (1997). Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteosome. Proc. Natl. Acad. Sci. USA 94, 1896-1901.
28. Jardetzky, T.S., Lane, W.S., Robinson, R.A., Madden, D.R., and Wiley, D.C. (1991). Identification of self peptides bound to purified HLA-B27. Nature 353, 326-329.
29. Kapasi, K., and Inman, R.D. (1992). HLA-B27 expression modulates gram-negative bacterial invasion into transfected L cells. J. Immunol. 148, 3554-3559.
30. Kavathas, P., and Herzenberg, L.A. (1983). Stable transformation of mouse L cells for human membrane T-cell differentiation antigens, HLA and beta 2-microglobulin: selection by fluorescence-activated cell sorting. Proc. Natl. Acad. Sci. USA 80, 524-528.
31. Khan, M.A. (1995). HLA-B27 and its subtypes in world populations. Curr. Opin. Rheumatol. 7, 263-269.
32. Khanna, R., Jacob, C.A., Burrows, S.R., Kurilla, M.G., Kieff, E., Misko, I.S., Sculley, T.B., and Moss, D.J. (1991). Expression of Epstein-Barr virus nuclear antigens in anti-igM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells. Immunology 74, 504-510.
33. Khare, S.J., Luthra, H.S., and David, C.S. (1995). Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking β2-microglobulin: a model of human spondyloarthropathies. J. Exp. Med. 182, 1153-1158.
34. Kropshofer, H., Vogt, A.B., Moldenhauer, G., Hammer, J., Blum, J.S., and Hammerling, G.J. (1996). Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J. 15, 6144-6154.
35. Lehner, P.J., Karttunen, J.T., Wilkinson, G.W.G., and Cresswell, P. (1997). The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc. Natl. Acad. Sci. USA 94, 6904-6909.
36. Lehner, P.J., Surman, M.J., and Cresswell, P. (1998). Soluble tapasin restores MHC class I expression and function in thetapasin-negative cell line. 220. Immunity 8, 221-231.
37. Lewis, J.W., Neisig, A., Neefjes, J., and Elliott, T. (1996). Point mutations in the alpha 2 domain of HLA-A2.1 define afunctionally relevant interaction with TAP. Curr. Biol. 6, 873-883.
38. Ljunggren, H., Stam, N.J., Ohlen, C., Neefjes, J.J., Hoglund, P., Heemels, M., Bastin, J., Schumacher, T.N.M., Townsend, A., Karre, K., and Ploegh, H. (1990). Empty MHC class I molecules come out in the cold. Nature 346, 476-480.
39. Meyer, T.H., van Endert, P.M., Uebel, S., Ehring, B., and Tampe, R. (1994). Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells. FEBS Lett. 351, 443-447.
40. Momburg, F., Roelse, J., Howard, J., Butcher, G.W., Hammerling, G.J., and Neefjes, J.J. (1994). Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 367, 648-651.
41. Murray, R.J., Kurilla, M.G., Brooks, J.M., Thomas, W.A., Rowe, M., Kieff, E., and Rickinson, A.B. (1992). Identification of target antigens for t he human cytotoxic T cell responses to Epstein-Barr virus (EBV): implications for the immune control of the EBV-positive malignancies. J. Exp. Med. 176, 157-168.
42. Neisig, A., Wubbolts, R., Zang, X., Melief, C., and Neefjes, J. (1996). Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J. Immunol. 156, 3196-3206.
43. Nö βner, E., and Parham, P. (1995). Species-specific differences in chaperone interaction of human and mouse major histocompatibility complex class I molecules. J. Exp. Med. 181, 327-337.
44. Ortmann, B., Androlewicz, M.J., and Cresswell, P. (1994). MHC class I/β2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 368, 864-867.
45. Ortmann, B., Copeman, J., Lehner, P.J., Sadasivan, B., Herberg, J.A., Grandea, A.G., Riddell, S.R., Tampe, R., Spies, T., Trowsdale, J., et al. (1997). A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 277, 1306-1309.
46. Parham, P. (1996). Presentation of HLA class I-derived peptides: potential involvement in allorecognition and HLA-B27 associated arthritis. Immunol. Rev. 154, 137-154.
47. Parham, P., Barnstable, C.J., and Bodmer, W.F. (1979). Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C antigens. J. Immunol. 123, 342-349.
48. Peace-Brewer, A.L., Tussey, L.G., Matsui, M., Li, G., Quinn, D.G., and Frelinger, J.A. (1996). A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL. Immunity 4, 505-514.
49. Rammensee, H.-G., Falk, K., and Rotzschke, O. (1993). Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11, 213-244.
50. Rickinson, A.B., and Moss, D.J. (1997). Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15, 405-431.
51. Sadasivan, B.K., Cariappa, A., Waneck, G.L., and Cresswell, P. (1995). Assembly, peptide loading, and transport of MHC class I molecules in a calnexin-negative cell line. Cold Spring Harbor Symp. Quant. Biol. LX, 267-275.
52. Sadasivan, B., Lehner, P.J., Ortmann, B., Spies, T., and Cresswell, P. (1996). Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5, 103-114.
53. Salter, R.D., Howell, D.N., and Cresswell, P. (1985). Genes regulating HLA class I antigen expression inT-B lymphoblast hybrids. Immunogenetics 21, 235-246.
54. 3 domain of HLA-A molecules affects binding to CDS. Nature 338, 345-347.
55. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual. Second Edition. (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press).
56. Scott, J.E., and Dawson, J.R. (1995). MHC class I expression and transport in a calnexin-deficient cell line. J. Immunol. 155, 143-148.
57. Solheim, J.C., Harris, M.R., Kindle, C.S., and Hansen, T.H. (1997). Prominence of β2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. J. Immunol. 158, 2236-2241.
58. Stam, H.J., Spits, H., and Ploegh, H.L. (1986). Monoclonal antibodies raised aginst denatured HLA-B locus heavy chains permit biochemical characterisation of certain HLA-C locus products. J. Immunol. 137, 2299-2306.
59. Sugita, M., and Brenner, M.B. (1994). An unstable β2-microglobulin: major histocompatibility complex class I heavy chain intermediate dissociates from calnexin and then is stabilized by binding peptide. J. Exp. Med. 180, 2163-2171.
60. Suh, W.-K., Cohen-Doyle, M.F., Fruh, K., Wang, K., Peterson, P.A., and Williams, D.B. (1994). Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 264, 1322-1326.
61. Suh, W.-K., Mitchell, E.K., Yang, Y., Peterson, P.A., Waneck, G.L., and Williams, D.W. (1996). MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains. J. Exp. Med. 184, 337-348.
62. Thomsen, D.R., Stenberg, R.M., Goins, W.F., and Stinski, M.F. (1984). Promoter-regulatory region of the major immediate early gene of human cytomegalovirus. Proc. Natl. Acad. Sci. 81, 659-663.
63. Townsend, A., Ohlen, C., Bastin, J., Ljunggren, H.-G., Foster, L., and Karre, K. (1989). Association of class I major histocompatiblity heavy and light chains induced by viral peptides. Nature 340, 443-448.
64. Trapani, J.A., Vaughan, H.A., Sparrow, R.L., Tait, B.D., and McKenzie, I.F. (1983). Description of a mouse monoclonal anti HLA-B27 antibody, HLA-ABC-m3. Hum. Immunol. 7, 205-216.
65. Tussey, L.G., Rowland-Jones, S., Zheng, T.S., Androlewicz, M.J., Cresswell, P., Frelinger, J.A., and McMichael, A.J. (1995). Different MHC class I alleles compete for presentation of overlapping viral epitopes. Immunity 3, 65-77.
66. Urban, R.G., Chicz, R.M., Lane, W.S., Strominger, J.L., Rehm, A., Kenter, M.J.H., UytdeHaag, F.G.C.M., Ploegh, H., Uchanska-Ziegler, B., and Ziegler, A. (1994). A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc. Natl. Acad. Sci. USA 91, 1534-1538.
67. Valerio, R.M., Benstead, M., Bray, A.M., Campbell, R.A., and Maeji, N.J. (1991). Synthesis of peptide analogues using the multipin peptide synthesis method. Anal. Biochem. 197, 168-177.
68. Vigna, J.L., Smith, K.D., and Lutz, C.T. (1996). Invariant chain association with MHC class I. Preference for HLA class I/β2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove. J. Immunol. 157, 4503-4510.
69. Wang, J., Yu, D.T.Y., Fukazawa, T., Kellner, H., Wen, J., Cheng, X.-K., Roth, G., Williams, K.M., Raybourne, R.B. (1994). A monoclonal antibody that recognises HLA-B27 in the context of peptides. J. Immunol. 152, 1197-1205.
70. Weber, D.A., Evavold, B.D., and Jensen, P.E. (1996). Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274, 618-620.
71. Wei, M.L., and Cresswell, P. (1992). HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356, 443-446.
72. Weiss, E.H., Kuon, W., Dorner, C., Lang, M., and Reithmuller, G. (1985). Organisation, sequence and expression of the HLA-B27 gene: a molecular approach to analyse HLA and disease associations, Immunobiology 170, 367-380.
73. Zemmour, J., Little, A.-M., Schendel, D.J., and Parham, P. (1992). The HLA-A, B "negative" mutant cell line C1R expressed a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol. 148, 1941-1948.